Suppr超能文献

奠基人群中心血管危险因素及亚临床血管病变的年龄和性别特异性知晓、治疗与控制:撒丁岛研究(SardiNIA研究)

Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.

作者信息

Scuteri A, Najjar S S, Orru' M, Albai G, Strait J, Tarasov K V, Piras M G, Cao A, Schlessinger D, Uda M, Lakatta E G

机构信息

UO Geriatria, INRCA, IRCCS, Via Cassia 1167, 00189 Rome, Italy.

出版信息

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):532-41. doi: 10.1016/j.numecd.2008.11.004. Epub 2009 Mar 25.

Abstract

AIM

We investigated the gender-specific control of cardiovascular (CV) risk factors and subclinical vascular lesions in a founder population in Italy.

METHODS AND RESULTS

6148 subjects were enrolled (aged 14-102 years) from four towns. Hypertension (HT), diabetes mellitus (DM) and dyslipidemia (LIP) were defined in accordance with guidelines. A self-reported diagnosis defined awareness of these conditions, and the current use of specific medications as treatment. Prevalence was HT 29.2%, DM 4.8%, LIP 44.1% and was higher in men than in women. Disease prevalence increased with age for every CV risk factor. Men were less likely than women to take anti-HT drugs and to reach BP control (9.9% vs. 16%). Only 17.6% of HT > 65 years had a BP < or =140/90 mmHg, though 48.5% were treated. The use of statins was very low (<1/3 of eligible subjects > 65 years, those with the highest treatment rate). The ratio of control-to-treated HT was lower in subjects with, than in those without, thicker carotid arteries (31.5% vs. 38.8%, p < 0.05) or stiffer aortas (26.0% vs. 40.0%, p < 0.05) or carotid plaques (26.3% vs. 41.1%, p<0.05).

CONCLUSION

A large number of subjects at high CV risk are not treated and the management of subclinical vascular lesions is far from optimal.

摘要

目的

我们在意大利的一个创始人群体中研究了心血管(CV)危险因素和亚临床血管病变的性别特异性控制情况。

方法与结果

从四个城镇招募了6148名受试者(年龄14 - 102岁)。高血压(HT)、糖尿病(DM)和血脂异常(LIP)根据指南进行定义。自我报告的诊断确定了对这些疾病的知晓情况,以及当前使用特定药物进行治疗的情况。患病率分别为HT 29.2%、DM 4.8%、LIP 44.1%,男性高于女性。每种CV危险因素的疾病患病率均随年龄增加。男性服用抗高血压药物并达到血压控制的可能性低于女性(9.9%对16%)。尽管48.5%的65岁以上高血压患者接受了治疗,但只有17.6%的患者血压<或=140/90 mmHg。他汀类药物的使用率非常低(65岁以上符合条件的受试者中<1/3,这些人治疗率最高)。有颈动脉增厚、主动脉僵硬或颈动脉斑块的受试者中,高血压控制与治疗的比例低于没有这些情况的受试者(31.5%对38.8%,p<0.05;26.0%对40.0%,p<0.05;26.3%对41.1%,p<0.05)。

结论

大量具有高CV风险的受试者未得到治疗,亚临床血管病变的管理远未达到最佳状态。

相似文献

2
Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
J Cardiometab Syndr. 2006 Fall;1(5):358-61. doi: 10.1111/j.1559-4564.2006.06035.x.
3
Change in cardiovascular risk factors in relation to diabetes status: the Tromso Study.
Eur J Prev Cardiol. 2012 Jun;19(3):551-7. doi: 10.1177/1741826711408147. Epub 2011 Apr 19.
4
Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105304. doi: 10.1016/j.jstrokecerebrovasdis.2020.105304. Epub 2020 Sep 22.
9
Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
J Cardiometab Syndr. 2006 Spring;1(2):133-40. doi: 10.1111/j.1559-4564.2006.05487.x.

引用本文的文献

2
The Cholesterol Paradox in Long-Livers from a Sardinia Longevity Hot Spot (Blue Zone).
Nutrients. 2025 Feb 21;17(5):765. doi: 10.3390/nu17050765.
4
Awareness of having hypertension, diabetes and dyslipidaemia among US adults: The 2011-2018 NHANES data.
Scand J Public Health. 2025 Jun;53(4):391-399. doi: 10.1177/14034948241247612. Epub 2024 Apr 28.
5
Genetic and biomarker modulation of arterial stiffness change in the SardiNIA population cohort.
Front Epidemiol. 2024 Jan 4;3:1295209. doi: 10.3389/fepid.2023.1295209. eCollection 2023.
6
Subclinical HMOD in Hypertension: Brain Imaging and Cognitive Function.
High Blood Press Cardiovasc Prev. 2022 Nov;29(6):577-583. doi: 10.1007/s40292-022-00546-1. Epub 2022 Nov 21.
7
Gender and physical frailty modify the association between abdominal obesity and functional disability in older adults.
Aging Clin Exp Res. 2022 Sep;34(9):2013-2021. doi: 10.1007/s40520-022-02167-z. Epub 2022 Jun 25.
8
Predicting physiological aging rates from a range of quantitative traits using machine learning.
Aging (Albany NY). 2021 Oct 29;13(20):23471-23516. doi: 10.18632/aging.203660.
9
Circulating fatty acids and endocannabinoidome-related mediator profiles associated to human longevity.
Geroscience. 2021 Aug;43(4):1783-1798. doi: 10.1007/s11357-021-00342-0. Epub 2021 Mar 1.
10
Impact of Stiffer Arteries on the Response to Antihypertensive Treatment: A Longitudinal Study of the SardiNIA Cohort.
J Am Med Dir Assoc. 2020 Jun;21(6):720-725. doi: 10.1016/j.jamda.2019.11.014. Epub 2019 Dec 26.

本文引用的文献

1
Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
Nat Genet. 2008 Feb;40(2):161-9. doi: 10.1038/ng.76. Epub 2008 Jan 13.
6
7
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.
Hypertension. 2007 Jan;49(1):69-75. doi: 10.1161/01.HYP.0000252676.46043.18. Epub 2006 Dec 11.
8
Heritability of cardiovascular and personality traits in 6,148 Sardinians.
PLoS Genet. 2006 Aug 25;2(8):e132. doi: 10.1371/journal.pgen.0020132. Epub 2006 Jul 10.
10
Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project.
Eur J Cardiovasc Prev Rehabil. 2006 Feb;13(1):13-29. doi: 10.1097/00149831-200602000-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验